Maghsoud Dariani

Maghsoud Dariani is CSO at Lobe Sciences. Mr Dariani has significant experience as an entrepreneurial business leader with a strong background in technology development. He was President at Focus Pharmaceuticals where he managed the development and approval of drug products, achieving one FDA approval and bringing another to the clinical evaluation stage. During his time at Celgene Corporation, Mr Dariani was responsible for the successful development and FDA approval of the chirally pure versions of Ritalin which are now sold by Novartis.